124257-63-2

Usage

Uses

The specific uses of (1-Benzyl-1,2,5,6-tetrahydropyridin-3-yl)methanamine would need to be determined through further research and testing, as the provided materials do not specify any particular applications. However, given its structure and the potential pharmacological or biological activity of tetrahydropyridine derivatives, it is possible that (1-Benzyl-1,2,5,6-tetrahydropyridin-3-yl)methanamine could have uses in various industries, such as pharmaceuticals, agrochemicals, or materials science. Further investigation would be required to confirm its suitability and efficacy for any specific applications.

Upstream product

• 124257-64-3 3-<(acetylamino)methyl>-1-benzyltetrahydropyridin-3-ene 

Relevant academic research and scientific papers

Development of potent serotonin-3 (5-HT3) receptor antagonists. I. Structure-activity relationships of 2-alkoxy-4-amino-5-chlorobenzamide derivatives

A new series of 2-alkoxy-4-amino-5-chlorobenzamide derivatives hearing five- to seven-membered heteroalicyclic rings in the amine moiety was synthesized and evaluated for serotonin-3 (5-HT3) receptor antagonistic activity by assaying the ability to antagonize the yon Bezold-Jarisch reflex in rats. The five- to seven-membered heteroalicycles comprise pyrrolidine, morpholine, 1,4-thiazine, piperidine, piperazine, 1,4-oxazepine, 1,4- thiazepine, azepine, and 1,4-diazepine rings. Among them, some benzamide derivatives having a 1,4-diazepine ring showed a potent 5-HT3 receptor antagonistic activity. In particular, 4-amino-5-chloro-N-(1,4- dimethylhexahydro-1H-1,4-diazepin-6-yl)-2-ethoxyhenzamide (96) and the 1- benzyl-4-methylhexahydro-1H-1,4-diazepine analogue 103 showed potent 5-HT3 receptor antagonistic activity without 5-HT4 receptor binding affinity.